Clinical Trials Directory

Trials / Completed

CompletedNCT02113423

Intensity Modulated Radiotherapy in Recurrent T1-2 Nasopharyngeal Carcinoma

Superiority of Intensity Modulated Radiotherapy in Recurrent T1-2 Nasopharyngeal Carcinoma

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
168 (actual)
Sponsor
Fujian Cancer Hospital · Other Government
Sex
All
Age
16 Years – 75 Years
Healthy volunteers
Not accepted

Summary

The hypothesis of the study is to address the efficacy and toxicity profile of aforementioned four modalities for rT1-2 NPC. Characters of the patients: * list item one: 168 patients, median age 48 years (range 16-75 years) proven rT1-2 NPC were diagnosed * list item two: Treated with four different irradiation modalities(3D-CRT,IMRT, BT , BT Combined 3D-CRT or IMRT). * list item three: Median time to recurrence was 30 months (range 1-180months). The median follow-up time was 28 months (range, 4-135 months).

Detailed description

Objectives: Recurrent T1-2 Nasopharyngeal Carcinoma (rT1-2) may be salvaged by 3D - CRT(3D-Conformal Radiotherapy), IMRT( Intensity Modulated Radiotherapy), Brachytherapy (BT), BT combined 3D - CRT or IMRT . The aim of this study is to address the efficacy and toxicity profile of aforementioned four modalities for rT1-2 NPC. Methods and Materials: 168 patients, median age 48 years (range 16-75 years) proven rT1-2 NPC were diagnosed and treated with four different irradiation modalities(3D-CRT,IMRT, BT , BT Combined 3D-CRT or IMRT) . Median time to recurrence was 30 months (range 1-180months). The median follow-up time was 28 months (range, 4-135 months).

Conditions

Interventions

TypeNameDescription
RADIATION3D-CRT, IMRT, BT, BT combined 3D-CRT or IMRT3D - CRT(3D-Conformal Radiotherapy): CTV-P 50-60Gy(2 Gy or 1.8 Gy per daily fraction, 5 days per week) IMRT(Intensity Modulated Radiotherapy): GTV-P 50-60 Gy(2 Gy or 1.8 Gy per daily fraction, 5 days per week) BT(Brachytherapy): 2.5Gy BID\*10F one week interval BT combined 3D - CRT or IMRT: First,GTV-P 40Gy(2 Gy or 1.8 Gy per daily fraction, 5 days per week);Then, 2.5Gy BID\*2F

Timeline

Start date
1996-01-01
Primary completion
2009-06-01
Completion
2011-03-01
First posted
2014-04-14
Last updated
2014-04-14

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT02113423. Inclusion in this directory is not an endorsement.

Intensity Modulated Radiotherapy in Recurrent T1-2 Nasopharyngeal Carcinoma (NCT02113423) · Clinical Trials Directory